StockData
Lantheus Holdings, Inc. logo

Lantheus Holdings, Inc. (LNTH) stock

LNTHNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 11/3014% above fair value
$102.00+0.20 (+0.20%)

Close on Nov 18, 2026Market cap $6.66BP/E 24.7Yield –

Lantheus free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Lantheus's free cash flow for the twelve months ending Dec 31, 2023 was $259.92M, up 1093.3% year over year. For fiscal 2023 it was $259.92M, up 1093.3% from the year before. The highest annual figure on record is $259.92M in fiscal 2023.

Annual free cash flow

PeriodPeriod endValueChange
FY2023Dec 31, 2023$259.92M+1093.3%
FY2022Dec 31, 2022$21.78M-59.6%
FY2021Dec 31, 2021$53.92M+228.8%
FY2020Dec 31, 2020$16.40M-71.9%
FY2019Dec 31, 2019$58.32M+42.0%
FY2018Dec 31, 2018$41.06M+10.3%
FY2017Dec 31, 2017$37.23M-11.9%
FY2016Dec 31, 2016$42.24M+390.6%
FY2015Dec 31, 2015$8.61M+149.4%
FY2014Dec 31, 2014$3.45M–
FY2013Dec 31, 2013-$20.58M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2023Dec 31, 2023$112.29M–
Q3 FY2023Sep 30, 2023$116.74M+24.8%
Q2 FY2023Jun 30, 2023-$42.27M-158.2%
Q1 FY2023Mar 31, 2023$73.16M+612.7%
Q4 FY2022Dec 31, 2022-$154.65M-819.8%
Q3 FY2022Sep 30, 2022$93.57M+4773.3%
Q2 FY2022Jun 30, 2022$72.60M+212.7%
Q1 FY2022Mar 31, 2022$10.26M+40.6%
Q4 FY2021Dec 31, 2021$21.49M+132.1%
Q3 FY2021Sep 30, 2021$1.92M-60.3%
Q2 FY2021Jun 30, 2021$23.21M–
Q1 FY2021Mar 31, 2021$7.30M+8.8%
Q4 FY2020Dec 31, 2020$9.26M-47.6%
Q3 FY2020Sep 30, 2020$4.84M-79.1%
Q2 FY2020Jun 30, 2020-$4.41M-125.0%
Q1 FY2020Mar 31, 2020$6.71M–
Q4 FY2019Dec 31, 2019$17.68M+77.9%
Q3 FY2019Sep 30, 2019$23.11M+19.9%
Q2 FY2019Jun 30, 2019$17.62M+20.3%
Q1 FY2019Mar 31, 2019-$82.00K–
Q4 FY2018Dec 31, 2018$9.94M+39.4%
Q3 FY2018Sep 30, 2018$19.27M+56.5%
Q2 FY2018Jun 30, 2018$14.65M-14.7%
Q1 FY2018Mar 31, 2018-$2.80M-548.2%
Q4 FY2017Dec 31, 2017$7.13M-31.2%
Q3 FY2017Sep 30, 2017$12.31M-4.2%
Q2 FY2017Jun 30, 2017$17.17M–
Q1 FY2017Mar 31, 2017$625.00K–
Q4 FY2016Dec 31, 2016$10.36M–
Q3 FY2016Sep 30, 2016$12.86M–

More Lantheus figures

See a number that looks wrong?